Becton, Dickinson and Company (BDX) reported earnings for its first quarter that increased from the same period last year and beat ...

Barclays analyst Matt Miksic maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $278.00. The ...

Becton Dickinson & Co. closed 9.83% short of its 52-week high of $251.99, which the company reached on February 3rd.

Becton Dickinson shares have climbed 8% since the beginning of the year, while the S&P's 500 index has increased 27%. In the final minutes of trading on Wednesday, shares hit $245.06, a rise of 4% in ...

Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The ...

Becton Dickinson plans to break off its biosciences and diagnostic solutions business and focus on the medtech sector. The company said late Wednesday the split could take the form of a sale ...

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Becton Dickinson (NYSE:BDX). Even if this company is fairly valued by ...

Becton Dickinson Announces Strategic Business Separation Plan BD sees FY25 adjusted EPS $14.30-$14.60 vs. previous view $14.25-$14.60 Becton Dickinson to separate biosciences, diagnostic solutions ...

Bengaluru: Becton Dickinson beat expectations for first-quarter results and said its board has authorized a plan to separate its life sciences unit on Wednesday, as the medical device maker aims ...

Shares of Becton Dickinson & Co. BDX slid 7.28% to $227.21 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.36% to 6,083 ...

Becton Dickinson shares have climbed 8% since the beginning of the year, while the S&P’s 500 index has increased 27%. In the final minutes of trading on Wednesday, shares hit $245.06, a rise of ...

Bengaluru: U.S. medical device maker Becton Dickinson is considering a potential separation of its life sciences unit at a valuation of about $30 billion, a person familiar with the matter said on ...